RECRUITING

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: a Single Arm Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

Official Title

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: a Single Arm Study

Quick Facts

Study Start:2025-05
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06695156

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of migraine with or without aura, based on ICHD3 criteria
  2. * 6-14 migraine days/month.
  3. * ≥ one year history of migraines starting before the age of 50.
  4. * ≥ 18 years old or ≤ 55 Years old
  5. * Willing to attend follow-up sessions.
  6. * Willing to practice TM twice a day for 20 minutes.
  7. * Agreeable to participate and to be randomized to either group.
  8. * Fluent in English.
  1. * \> 55 years old or \< 18 Years old
  2. * Already practicing Transcendental Meditation.
  3. * Pre-diagnosed major systemic illness or unstable medical/psychiatric condition (eg, suicide risk) requiring immediate treatment or that could compromise protocol adherence
  4. * Medication overuse headache (MOH)
  5. * Current/planned pregnancy or breastfeeding
  6. * New prophylactic migraine medicine started within 4 weeks of the screening visit
  7. * Unwilling to maintain stable migraine medication dosages
  8. * Failure to complete baseline headache logs.

Contacts and Locations

Study Contact

Asha Sharma, MS
CONTACT
5158092899
asharma@miu.edu
Dr. Jamie Grant, EdD
CONTACT
831-325-7637
jgrant@tm.org

Principal Investigator

Dr. Fred T Travis, PhD
STUDY_CHAIR
Maharishi International University

Study Locations (Sites)

Georgetown Headache Center and DC area
Washington, District of Columbia, 20036
United States

Collaborators and Investigators

Sponsor: Maharishi International University

  • Dr. Fred T Travis, PhD, STUDY_CHAIR, Maharishi International University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05
Study Completion Date2025-12

Study Record Updates

Study Start Date2025-05
Study Completion Date2025-12

Terms related to this study

Keywords Provided by Researchers

  • Migraine
  • Meditation
  • Transcendental Meditation

Additional Relevant MeSH Terms

  • Migraine
  • Migraine with or Without Aura